Novamind

Bionomics is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for central nervous system disorders and cancer in Australia and the United States. Its lead program, BNC210, is a selective negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor studied for anxiety, panic, agitation, and post-traumatic stress disorder. The company’s portfolio also includes BNC105, a vascular disrupting agent for solid tumors; BNC101, a monoclonal antibody targeting cancer stem cells; and BNC375, a compound aimed at cognitive impairment in Alzheimer's disease. Bionomics also develops ionX, a genomics platform that supports its drug discovery efforts, and maintains strategic partnerships with industry collaborators to advance its therapies.

Cedar Psychiatry is a healthcare provider based in Springville, Utah, specializing in various mental health services. The company offers diagnostic assessments, medication management, and individual and family therapy, along with innovative treatments such as ketamine-assisted psychotherapy and transcranial magnetic stimulation (TMS). Additionally, Cedar Psychiatry provides palliative care and group therapy, focusing on comprehensive approaches to mental wellness. Clients can easily reach the company for inquiries through phone, email, and online applications.

Synthesis Institute B.V. operates a medical psilocybin retreat center based in Amsterdam, the Netherlands. Founded in 2017, the company focuses on providing a comprehensive approach to psychedelic wellness, offering services that include health screenings, coaching, educational workshops, group integration, and accommodation. Synthesis aims to create transformative experiences through professionally administered psilocybin, catering to individuals seeking alternative therapies. Additionally, the organization supports research into the effects of psychedelics, facilitating new modes of study for researchers in a controlled and professional environment. By combining wellness practices with scientific inquiry, Synthesis is at the forefront of the evolving field of psychedelic therapy.